Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Medicure Inc

Market Cap 12.52M 8.84M 7.73M 7.15M 6.67M 836M 12.62M 84.93M 33.05M 411M 33.2M 32.48M 1.43B P/E 2024
-8.8x
P/E 2025 -1.68x
Enterprise Value 9.58M 6.76M 5.91M 5.47M 5.1M 639M 9.65M 64.97M 25.28M 314M 25.4M 24.85M 1.09B EV / Sales 2024
0.13x
EV / Sales 2025 0.31x
Free-Float
73.4%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 79 15/09/1997
Director of Finance/CFO - 01/06/2022
Chief Tech/Sci/R&D Officer - 01/07/2019
Director TitleAgeSince
Chairman 79 15/09/1997
Director/Board Member 92 28/02/2000
Director/Board Member 56 22/01/2013
Change 5-day change 1-year change 3-year change Capi.($)
-5.23%+0.16% - - 8.83M
+2.87%+4.57%+70.82%+119.22% 55.19B
+4.00%+7.14%+63.67%+68.77% 45.75B
+0.36%+0.26%-11.62%-15.16% 22.98B
+3.28%+1.19%-6.46%+384.83% 20.76B
-0.26%-1.09%+27.55%-18.57% 16.26B
+1.16%+3.86%+22.36%-36.42% 15.42B
-1.43%-3.35%+18.11%+157.67% 13.05B
+3.30%+15.38%+133.24%+273.89% 12.45B
-5.63%-5.49%+21.79% - 12.37B
Average +0.25%+3.15%+37.72%+116.78% 23.8B
Weighted average by Cap. +1.80%+2.66%+43.77%+108.85%

Financials

2024 2025
Net sales 21.91M 15.47M 13.52M 12.5M 11.67M 1.46B 22.07M 149M 57.81M 719M 58.08M 56.82M 2.5B 28.86M 20.37M 17.8M 16.47M 15.37M 1.93B 29.07M 196M 76.14M 947M 76.5M 74.84M 3.29B
Net income -1.04M -734K -641K -593K -553K -69.33M -1.05M -7.05M -2.74M -34.09M -2.75M -2.69M -118M -7.1M -5.01M -4.38M -4.05M -3.78M -474M -7.15M -48.13M -18.73M -233M -18.81M -18.41M -809M
Net Debt -6.32M -4.46M -3.9M -3.61M -3.36M -422M -6.36M -42.84M -16.67M -207M -16.75M -16.38M -720M -2.94M -2.08M -1.82M -1.68M -1.57M -196M -2.97M -19.97M -7.77M -96.58M -7.8M -7.64M -336M
Logo Medicure Inc
Medicure Inc. is a pharmaceutical company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. Its primary focus is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through its United States subsidiary, Medicure Pharma Inc. It operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medications for all Americans, together with customer service and free home delivery. It operates Gateway Medical Pharmacy, located in Portland, Oregon in a medical office building near transportation lines and multiple healthcare clinics and centers. It develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, and compositions containing P5P Analogues.
Employees
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!